This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

 
 
  S.B. No. 1645
 
 
 
 
AN ACT
  relating to the distribution of a prescription drug and a study of
  the feasibility of establishing separate reimbursement under the
  Medicaid vendor drug program for certain pharmacy care management
  services.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  DEFINITION. In this Act, "pharmacy care
  management services" means services provided by a pharmacy to
  support patients receiving treatment or therapy through a specialty
  pharmacy drug or therapy and maximize adherence to the drug or
  therapy, including:
               (1)  significant caregiver and provider contact and
  education regarding the relevant disease, disease prevention and
  treatment, and counseling related to drug indications, benefits,
  risks, complications, and appropriate use of the prescribed drug or
  therapy;
               (2)  patient compliance services, including
  coordination of provider visits with delivery of the specialty drug
  or therapy to the provider, compliance with the dosing regimen,
  patient reminders, compilation of data, and assisting providers in
  the development of compliance programs; and
               (3)  tracking services, including developing ordering
  processes with a provider, screening referrals, and tracking a
  patient's weight for dosing requirements.
         SECTION 2.  STUDY. (a)  The Health and Human Services
  Commission shall study the feasibility of establishing separate
  reimbursement rates under the Medicaid vendor drug program for
  pharmacies that provide pharmacy care management services to
  patients who are administered specialty pharmacy drugs, including
  drugs indicated for the prophylaxis of respiratory syncytial virus,
  blood factor, or any other biologic or therapy that requires
  complex care.
         (b)  In conducting the study under Subsection (a) of this
  section, the Health and Human Services Commission shall consult
  with the Centers for Medicare and Medicaid Services and may
  consider the adoption of pharmacy care management services
  reimbursement for pharmacy services adopted by other state Medicaid
  programs.
         (c)  The Health and Human Services Commission shall seek
  information from specialty pharmacy providers or other sources
  regarding the costs of providing pharmacy care management services.
         (d)  Not later than September 1, 2010, the Health and Human
  Services Commission shall submit a written report of the results of
  the study conducted under Subsection (a) of this section to the
  legislature.
         SECTION 3.  NORMAL DISTRIBUTION CHANNEL.  Subdivision (5),
  Section 431.401, Health and Safety Code, is amended to read as
  follows:
               (5)  "Normal distribution channel" means a chain of
  custody for a prescription drug, either directly or by drop
  shipment, from the manufacturer of the prescription drug, the
  manufacturer to the manufacturer's co-licensed product partner,
  the manufacturer to the manufacturer's third-party logistics
  provider, or the manufacturer to the manufacturer's exclusive
  distributor, to:
                     (A)  a pharmacy to:
                           (i)  a patient; or
                           (ii)  another designated person authorized
  by law to dispense or administer the drug to a patient;
                     (B)  an authorized distributor of record to:
                           (i)  a pharmacy to a patient; or
                           (ii)  another designated person authorized
  by law to dispense or administer the drug to a patient;
                     (C)  an authorized distributor of record to a
  wholesale distributor licensed under this chapter to another
  designated person authorized by law to administer the drug to a
  patient;
                     (D)  an authorized distributor of record to a
  pharmacy warehouse to the pharmacy warehouse's intracompany
  pharmacy;
                     (E) [(D)]  a pharmacy warehouse to the pharmacy
  warehouse's intracompany pharmacy or another designated person
  authorized by law to dispense or administer the drug to a patient;
                     (F) [(E)]  a person authorized by law to prescribe
  a prescription drug that by law may be administered only under the
  supervision of the prescriber; or
                     (G) [(F)]  an authorized distributor of record to
  one other authorized distributor of record to a licensed
  practitioner for office use.
         SECTION 4.  EXEMPTION FROM CERTAIN PROVISIONS FOR CERTAIN
  WHOLESALE DISTRIBUTORS. Section 431.4031, Health and Safety Code,
  is amended to read as follows:
         Sec. 431.4031.  EXEMPTION FROM CERTAIN PROVISIONS FOR
  CERTAIN WHOLESALE DISTRIBUTORS. (a)  A wholesale distributor that
  distributes prescription drugs that are medical gases or a
  wholesale distributor that is a manufacturer or a third-party
  logistics provider on behalf of a manufacturer is exempt from
  Sections 431.404(a)(5) and (6), (b), and (c), 431.4045(2), 431.405,
  431.407, and 431.408.
         (b)  A state agency or a political subdivision of this state
  that distributes prescription drugs using federal or state funding
  to nonprofit health care facilities or local mental health or
  mental retardation authorities for distribution to a pharmacy,
  practitioner, or patient is exempt from Sections 431.405(b),
  431.407, 431.408, 431.412, and 431.413.
         (c)  The executive commissioner of the Health and Human
  Services Commission by rule may exempt specific purchases of
  prescription drugs by state agencies and political subdivisions of
  this state if the executive commissioner determines that the
  requirements of this subchapter would result in a substantial cost
  to the state or a political subdivision of the state.
         SECTION 5.  RULES. As soon as practicable after the
  effective date of this Act, the executive commissioner of the
  Health and Human Services Commission shall adopt, modify, or repeal
  rules as necessary to implement the changes in law made by this Act
  to Chapter 431, Health and Safety Code.
         SECTION 6.  EFFECTIVE DATE. This Act takes effect
  immediately if it receives a vote of two-thirds of all the members
  elected to each house, as provided by Section 39, Article III, Texas
  Constitution. If this Act does not receive the vote necessary for
  immediate effect, this Act takes effect September 1, 2009.
 
 
 
 
 
 
  ______________________________ ______________________________
     President of the Senate Speaker of the House     
 
         I hereby certify that S.B. No. 1645 passed the Senate on
  May 7, 2009, by the following vote:  Yeas 31, Nays 0; May 30, 2009,
  Senate refused to concur in House amendment and requested
  appointment of Conference Committee; May 30, 2009, House granted
  request of the Senate; May 31, 2009, Senate adopted Conference
  Committee Report by the following vote:  Yeas 31, Nays 0.
 
 
  ______________________________
  Secretary of the Senate    
 
         I hereby certify that S.B. No. 1645 passed the House, with
  amendment, on May 27, 2009, by the following vote:  Yeas 137,
  Nays 11, one present not voting; May 30, 2009, House granted
  request of the Senate for appointment of Conference Committee;
  May 31, 2009, House adopted Conference Committee Report by the
  following vote:  Yeas 141, Nays 0, one present not voting.
 
 
  ______________________________
  Chief Clerk of the House   
 
 
 
  Approved:
 
  ______________________________ 
             Date
 
 
  ______________________________ 
            Governor